64
|
170
|
7a1xA |
Krasg12c gdp form in complex with cpd1 |
66
|
169
|
7a1yA |
Krasg12c gdp form in complex with cpd2 |
67
|
183
|
7rseA |
Nmr-driven structure of the kras4b-g12d "alpha-beta" dimer on a lipid bilayer nanodisc |
83
|
187
|
7rscD |
Nmr-driven structure of the kras4b-g12d "alpha-alpha" dimer on a lipid bilayer nanodisc |
62
|
183
|
7rscA |
Nmr-driven structure of the kras4b-g12d "alpha-alpha" dimer on a lipid bilayer nanodisc |
83
|
187
|
7rseD |
Nmr-driven structure of the kras4b-g12d "alpha-beta" dimer on a lipid bilayer nanodisc |
58
|
169
|
7lgiA |
The haddock model of gdp kras in complex with promazine using chemical shift perturbations and intermolecular noes |
19
|
81
|
7lc2D |
Crystal structure of kras4b-q61r (gmppnp-bound) in complex with the ras-binding domain (rbd) of sin1 |
46
|
167
|
7lc2A |
Crystal structure of kras4b-q61r (gmppnp-bound) in complex with the ras-binding domain (rbd) of sin1 |
18
|
91
|
7ny8C |
Affimer k69 - kras protein complex |
65
|
168
|
7ny8A |
Affimer k69 - kras protein complex |
61
|
168
|
7c41A |
Kras g12v and h-rev107 peptide complex |
0
|
10
|
7c41D |
Kras g12v and h-rev107 peptide complex |
58
|
168
|
7c40A |
Mggdp bound kras g12v |
52
|
168
|
7kfzA |
Structure of a ternary kras(g13d)-sos complex |
142
|
479
|
7kfzB |
Structure of a ternary kras(g13d)-sos complex |
56
|
168
|
6vc8A |
Crystal structure of wild-type kras4b(1-169) in complex with gmppnp and mg ion |
61
|
167
|
7acqA |
Crystal structure of inactive kras g12d (gdp) in complex with the soaked dimeric inhibitor bi-5747 |
62
|
169
|
7acfA |
Crystal structure of crystal form 2 of an active kras g12d (gppcp) dimer in complex with bi-5747 |
58
|
167
|
7achA |
Crystal structure of active kras g12d (gppcp) in complex with the soaked dimeric inhibitor bi-5747 |
62
|
167
|
7acaA |
Crystal structure of an active kras g12d (gppcp) dimer in complex with bi-5747 |
54
|
168
|
6xguA |
Crystal structure of kras-q61r (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf |
24
|
134
|
6xguB |
Crystal structure of kras-q61r (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf |
69
|
168
|
6vjjA |
Crystal structure of wild-type kras4b (gmppnp-bound) in complex with ras-binding domain (rbd) of raf1/craf |
66
|
169
|
6xi7A |
Crystal structure of wild-type kras (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf (crystal form i) |
17
|
77
|
6vjjB |
Crystal structure of wild-type kras4b (gmppnp-bound) in complex with ras-binding domain (rbd) of raf1/craf |
24
|
130
|
6xi7B |
Crystal structure of wild-type kras (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf (crystal form i) |
23
|
134
|
6xgvB |
Crystal structure of kras-g13d (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf |
64
|
168
|
6xgvA |
Crystal structure of kras-g13d (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf |
23
|
134
|
6xhbB |
Crystal structure of wild-type kras (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf (crystal form ii) |
59
|
168
|
6xhbA |
Crystal structure of wild-type kras (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf (crystal form ii) |
0
|
15
|
6wgnE |
Crystal structure of k-ras(g12d) gppnhp bound to cyclic peptide ligand kd2 |
64
|
169
|
6wgnA |
Crystal structure of k-ras(g12d) gppnhp bound to cyclic peptide ligand kd2 |
58
|
167
|
6zliA |
Crystal structure of kras-g12d in complex with compound 13 and gcp |
61
|
168
|
6zl5A |
Crystal structure of kras-g12d(c118s) in complex with bi-2852 and gdp |
14
|
89
|
6yxwB |
Affimer k3 - kras protein complex |
65
|
166
|
6yxwA |
Affimer k3 - kras protein complex |
16
|
89
|
6yr8B |
Affimer k6 - kras protein complex |
60
|
168
|
6yr8A |
Affimer k6 - kras protein complex |
62
|
177
|
6pq3A |
Crystal structure of gdp-bound kras with ten residues long internal tandem duplication in the switch ii region |
61
|
167
|
6usxA |
Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer |
67
|
169
|
6uszA |
Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer |
57
|
169
|
6ut0A |
Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer |
58
|
168
|
6mtaA |
Kras mutant structure in complex with gtp analogue |
62
|
168
|
6ms9A |
Gdp-bound kras switch 1 mutant |
60
|
169
|
6mnxA |
Structural basis of impaired hydrolysis in kras mutant |
66
|
170
|
6tamA |
X-ray structure of human k-ras g12c in complex with covalent isoquinolinone inhibitor (compound 3) |
61
|
170
|
6tanA |
X-ray structure of human k-ras g12c in complex with covalent isoquinolinone inhibitor (compound 17) |
62
|
169
|
6o46A |
Crystal structure of human kras mutant in complex with gnp and phosphate |
62
|
170
|
6t5bA |
Krasg12c ligand complex |